March 18, 2024

1 Minute
Medicine

Novartis Invest $256 million in Singapore Biopharmaceutical Manufacturing Facility

Novartis recently announced it broke ground for the expansion of its biopharmaceutical manufacturing plant in Singapore. The $256 million investment will facilitate Novartis in deploying digital and automation solutions to enhance manufacturing productivity, improve operational...
Read More